Abstract
During the past three decades, the incidence of esophageal adenocarcinoma (EAC) in the US increased by 5- to 6-fold, with a yearly increase of 4–10%.1 The prognosis for EAC is extremely poor, and the 5 year survival rate is ~10%.1−3 Despite significant improvements in early diagnosis and treatment, the majority of deaths in EAC patients are attributable to metastases that are resistant to therapy.2,3
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
X. Chen, and C. S. Yang, Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention, Carcinogenesis 22, 1119–29 (2001).
S. Romagnoli, M. Roncalli, D. Graziani, B. Cassani, E. Roz, L. Bonavina, A. Peracchia, S. Bosari, and G. Coggi, Molecular alterations of Barrett’s esophagus on microdissected endoscopic biopsies, Lab Invest. 81, 241–7 (2001).
C. A. Eads, R. V. Lord, K. Wickramasinghe, T. I. Long, S. K. Kurumboor, L. Bernstein, J. H. Peters, S. R. DeMeester, T. R. DeMeester, K. A. Skinner, and P. W. Laird, Epigenetic patterns in the progression of esophageal adenocarcinoma, Cancer Res. 61, 3410–8 (2001).
J. Denekamp, Inadequate vasculature in solid tumours: consequences for cancer research strategies, BJR Suppl. 24, 111–7 (1992).
P. Vaupel, and M. Höckel, Blood supply, oxygenation status and metabolic micromilieu of breast cancers: characterization and therapeutic relevance, Int. J. Oncol. 17, 869–79 (2000).
M. Höckel, K. Schlenger, M. Mitze, U. Schaffer, and P. Vaupel, Hypoxia and Radiation Response in Human Tumors, Semin. Radial. Oncol. 6, 3–9 (1996).
G. U. Dachs, and D. J. Chaplin, Microenvironmental control of gene expression: implications for tumor angiogenesis, progression, and metastasis, Semin. Radial. Oncol. 8, 208–16 (1998).
G. U. Dachs, and G. M. Tozer, Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation, Eur. J Cancer 36, 1649–60 (2000).
T. G. Graeber, C. Osmanian, T. Jacks, D. E. Housman, C. J. Koch, S. W. Lowe, and A. J. Giaccia, Hypoxiamediated selection of cells with diminished apoptotic potential in solid tumours, Nature 379, 88–91 (1996).
N. Denko, C. Schindler, A. Koong, K. Laderoute, C. Green, and A. Giaccia, Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment, Clin. Cancer Res. 6, 480–7 (2000).
P. Okunieff, I. Ding, P. Vaupel, and M. Höckel, Evidence for and against hypoxia as the primary cause of tumor aggressiveness, Adv. Exp. Med. (in press), (2002).
A. S. Ljungkvist, J. Bussink, and P. F. Rijken, Changes in tumor hypoxia measured with a double hypoxic marker technique, Int. J. Radial. Oncol. Biol. Phys. 48, 1529–38 (2000).
K. Kokame, H. Kato, and T. Miyata, Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78BiP and novel genes, J. Biot Chem. 271, 29659–65 (1996).
K. Salnikow, M. V. Blagosklonny, H. Ryan, R. Johnson, and M. Costa, Carcinogenic nickel induces genes involved with hypoxic stress, Cancer Res. 60, 38–41 (2000).
H. Park, M. A. Adams, P. Lachat, F. Bosman, S. C. Pang, and C. H. Graham, Hypoxia induces the expression of a 43-kDa protein (PROXY-I) in normal and malignant cells. Biochem. Biophys. Res. Commun. 276, 321–8 (2000).
E.M. Lord, L. Harwell, and C. J. Koch, Detection of hypoxic cells by monoclonal antibody recognizing 2nitroimidazole adducts, Cancer Res. 53, 5721–6 (1993).
B. M. Fenton, S. F. Paoni, J. Lee, C. J. Koch, and E. M. Lord, Quantification of tumour vasculature and hypoxia by immunohistochemical staining and HbO2 saturation measurements, Br. J. Cancer. 79, 464–71 (1999).
B. M. Fenton, S. F. Paoni, B. K. Beauchamp, B. Tran, L. Liang, B. Grimwood, and I. Ding, Evaluation of microreginal variations in tumor hypoxia following the administration of endostatin, Adv. Exp. Med. (in press) (2002).
L. Zhang, S. Kharbanda, D. Chen, J. Bullocks, D. L. Miller, I. Y. Ding, J. Hanfelt, S. W. McLeskey, and F. G. Kern, MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice, Oncogene. 15, 2093–108 (1997).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this paper
Cite this paper
Ding, I., Okunieff, P., Liu, W., Fenton, B., Salnikow, K. (2003). A New Intrinsic Hypoxia Marker in Esophageal Cancer. In: Thorniley, M., Harrison, D.K., James, P.E. (eds) Oxygen Transport to Tissue XXV. Advances in Experimental Medicine and Biology, vol 540. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6125-2_32
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6125-2_32
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-3428-4
Online ISBN: 978-1-4757-6125-2
eBook Packages: Springer Book Archive